PortfoliosLab logo
NUS vs. COCO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NUS and COCO is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

NUS vs. COCO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nu Skin Enterprises, Inc. (NUS) and The Vita Coco Company, Inc. (COCO). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%December2025FebruaryMarchAprilMay
-83.63%
157.47%
NUS
COCO

Key characteristics

Sharpe Ratio

NUS:

-0.86

COCO:

0.77

Sortino Ratio

NUS:

-1.30

COCO:

1.26

Omega Ratio

NUS:

0.86

COCO:

1.18

Calmar Ratio

NUS:

-0.52

COCO:

1.00

Martin Ratio

NUS:

-1.16

COCO:

2.71

Ulcer Index

NUS:

41.77%

COCO:

12.20%

Daily Std Dev

NUS:

56.39%

COCO:

43.25%

Max Drawdown

NUS:

-94.29%

COCO:

-56.97%

Current Drawdown

NUS:

-93.83%

COCO:

-13.62%

Fundamentals

Market Cap

NUS:

$305.84M

COCO:

$1.94B

EPS

NUS:

-$2.95

COCO:

$1.01

PS Ratio

NUS:

0.18

COCO:

3.63

PB Ratio

NUS:

0.47

COCO:

6.99

Total Revenue (TTM)

NUS:

$1.31B

COCO:

$535.24M

Gross Profit (TTM)

NUS:

$887.79M

COCO:

$199.51M

EBITDA (TTM)

NUS:

-$105.69M

COCO:

$72.85M

Returns By Period

In the year-to-date period, NUS achieves a -13.39% return, which is significantly lower than COCO's -5.69% return.


NUS

YTD

-13.39%

1M

-8.07%

6M

-5.14%

1Y

-51.00%

5Y*

-23.77%

10Y*

-16.76%

COCO

YTD

-5.69%

1M

24.59%

6M

0.58%

1Y

31.31%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NUS vs. COCO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUS
The Risk-Adjusted Performance Rank of NUS is 1313
Overall Rank
The Sharpe Ratio Rank of NUS is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of NUS is 88
Sortino Ratio Rank
The Omega Ratio Rank of NUS is 1111
Omega Ratio Rank
The Calmar Ratio Rank of NUS is 1818
Calmar Ratio Rank
The Martin Ratio Rank of NUS is 2020
Martin Ratio Rank

COCO
The Risk-Adjusted Performance Rank of COCO is 7676
Overall Rank
The Sharpe Ratio Rank of COCO is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of COCO is 7171
Sortino Ratio Rank
The Omega Ratio Rank of COCO is 7272
Omega Ratio Rank
The Calmar Ratio Rank of COCO is 8383
Calmar Ratio Rank
The Martin Ratio Rank of COCO is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NUS vs. COCO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Nu Skin Enterprises, Inc. (NUS) and The Vita Coco Company, Inc. (COCO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for NUS, currently valued at -0.86, compared to the broader market-2.00-1.000.001.002.003.00
NUS: -0.86
COCO: 0.77
The chart of Sortino ratio for NUS, currently valued at -1.30, compared to the broader market-6.00-4.00-2.000.002.004.00
NUS: -1.30
COCO: 1.26
The chart of Omega ratio for NUS, currently valued at 0.86, compared to the broader market0.501.001.502.00
NUS: 0.86
COCO: 1.18
The chart of Calmar ratio for NUS, currently valued at -0.55, compared to the broader market0.001.002.003.004.005.00
NUS: -0.55
COCO: 1.00
The chart of Martin ratio for NUS, currently valued at -1.16, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
NUS: -1.16
COCO: 2.71

The current NUS Sharpe Ratio is -0.86, which is lower than the COCO Sharpe Ratio of 0.77. The chart below compares the historical Sharpe Ratios of NUS and COCO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-0.86
0.77
NUS
COCO

Dividends

NUS vs. COCO - Dividend Comparison

NUS's dividend yield for the trailing twelve months is around 4.05%, while COCO has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
NUS
Nu Skin Enterprises, Inc.
4.05%3.48%8.03%3.65%3.00%2.75%3.61%2.38%2.11%2.97%3.69%3.16%
COCO
The Vita Coco Company, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

NUS vs. COCO - Drawdown Comparison

The maximum NUS drawdown since its inception was -94.29%, which is greater than COCO's maximum drawdown of -56.97%. Use the drawdown chart below to compare losses from any high point for NUS and COCO. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-87.94%
-13.62%
NUS
COCO

Volatility

NUS vs. COCO - Volatility Comparison

Nu Skin Enterprises, Inc. (NUS) and The Vita Coco Company, Inc. (COCO) have volatilities of 15.68% and 15.25%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2025FebruaryMarchAprilMay
15.68%
15.25%
NUS
COCO

Financials

NUS vs. COCO - Financials Comparison

This section allows you to compare key financial metrics between Nu Skin Enterprises, Inc. and The Vita Coco Company, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00M20212022202320242025
445.55M
130.92M
(NUS) Total Revenue
(COCO) Total Revenue
Values in USD except per share items

NUS vs. COCO - Profitability Comparison

The chart below illustrates the profitability comparison between Nu Skin Enterprises, Inc. and The Vita Coco Company, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
62.7%
36.7%
(NUS) Gross Margin
(COCO) Gross Margin
NUS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Nu Skin Enterprises, Inc. reported a gross profit of 279.15M and revenue of 445.55M. Therefore, the gross margin over that period was 62.7%.
COCO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Vita Coco Company, Inc. reported a gross profit of 48.09M and revenue of 130.92M. Therefore, the gross margin over that period was 36.7%.
NUS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Nu Skin Enterprises, Inc. reported an operating income of -53.08M and revenue of 445.55M, resulting in an operating margin of -11.9%.
COCO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Vita Coco Company, Inc. reported an operating income of 19.29M and revenue of 130.92M, resulting in an operating margin of 14.7%.
NUS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Nu Skin Enterprises, Inc. reported a net income of -36.11M and revenue of 445.55M, resulting in a net margin of -8.1%.
COCO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Vita Coco Company, Inc. reported a net income of 18.88M and revenue of 130.92M, resulting in a net margin of 14.4%.